CATABASIS PHARMACEUTICALS, INC. ASSUMED WARRANT TO PURCHASE SHARES OF PREFERRED STOCKWarrant Agreement • March 11th, 2021 • Catabasis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 11th, 2021 Company Industry JurisdictionThis Assumed Warrant (this “Warrant”) is issued to Viridian, LLC (the “Holder”) by Catabasis Pharmaceuticals, Inc., a Delaware corporation (the “Company”). This Warrant and the Assumed Warrant to Purchase Shares of Common Stock of even date herewith being issued by the Company to the Holder (the “Assumed Common Stock Warrant”) are being issued pursuant to Section 7(b) of the Warrant to Purchase Shares of Common Stock issued by Quellis Biosciences, Inc. (“Quellis”) to the Holder as of December 14, 2020 (the “Original Warrant”) to effectuate the assumption by the Company of the Original Warrant pursuant to Section 3.2(b) of the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), among the Company, Quellis, Cabo Merger Sub I, Inc. and Cabo Merger Sub II, LLC. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Merger Agreement.
CATABASIS PHARMACEUTICALS, INC. ASSUMED WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • March 11th, 2021 • Catabasis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 11th, 2021 Company Industry JurisdictionThis Assumed Warrant (this “Warrant”) is issued to Viridian, LLC (the “Holder”) by Catabasis Pharmaceuticals, Inc., a Delaware corporation (the “Company”). This Warrant and the Assumed Warrant to Purchase Shares of Preferred Stock of even date herewith being issued by the Company to the Holder (the “Assumed Preferred Stock Warrant”) are being issued pursuant to Section 7(b) of the Warrant to Purchase Shares of Common Stock issued by Quellis Biosciences, Inc. (“Quellis”) to the Holder as of December 14, 2020 (the “Original Warrant”) to effectuate the assumption by the Company of the Original Warrant pursuant to Section 3.2(b) of the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), among the Company, Quellis, Cabo Merger Sub I, Inc. and Cabo Merger Sub II, LLC. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Merger Agreement.